本文へ移動
cccskills
無料GitHub で公開

endo-pa-screening-method-arr

Selects the aldosterone-to-renin ratio (ARR) method over hypokalemia for screening hypertensive patients for primary aldosteronism. Use when a clinician asks what test to use for screening hypertensive patients with resistant hypertension or unexplained hypokalemia for PA.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.4 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Use aldosterone-to-renin ratio for PA screening

STEP 1 — Gather Information

Collect seated morning blood sample for aldosterone and plasma renin activity (PRA) or direct renin concentration (DRC), serum potassium, and review current medications; ensure no dietary sodium restriction in prior days.
→ Proceed to measure aldosterone and renin.

STEP 2 — Rule In / Rule Out

Assess renin suppression: PRA ≤1 ng/mL/h or DRC ≤8.2 mU/L.
If not suppressed → screen negative, rule out PA.
If suppressed → proceed to evaluate aldosterone level and ARR.

STEP 3 — Classify or Stratify

Calculate ARR: aldosterone (ng/dL) ÷ PRA (ng/mL/h) or aldosterone (pmol/L) ÷ DRC (mU/L).
Apply cutoffs:

  • Immunoassay: aldosterone ≥10 ng/dL and ARR >20
  • LC-MS/MS: aldosterone ≥7.5 ng/dL and ARR >15 (≈25% lower threshold)
    If both criteria met → screen positive; otherwise → screen negative.
    → Classify screen result.

STEP 4 — Decide

If screen positive → order aldosterone suppression testing for confirmation before PA-specific therapy.
If screen negative but hypokalemia present → correct potassium to reference range and repeat screen.
→ Initiate confirmatory testing or repeat screening as appropriate.

Clinical Guardrails / Mimics / Pitfalls

Do not rely on hypokalemia alone for screening; do not ignore interfering medications (e.g., β-blockers, ACEi/ARBs) without per Table 6/7 strategies; do not screen during sodium restriction; do not use ARR cutoffs without adjusting for assay type (immunoassay vs LC-MS/MS); do not forget to measure potassium to avoid falsely low aldosterone interpretation.

Concrete Clinical Example

A 55-year-old with resistant hypertension (BP 168/94 mmHg) and K+ 3.9 mmol/L has seated morning aldosterone 14 ng/dL (immunoassay) and PRA 0.3 ng/mL/h → ARR 46.7 (>20) → screen positive → proceed to aldosterone suppression testing.

Source: Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2025, https://doi.org/10.1210/clinem/dgaf284

TODO: consider adding scripts/calc.py for the endo-pa-screening-method-arr calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する